VAOCLEST

Serial Number 98860191
688

Registration Progress

Application Filed
Nov 19, 2024
Under Examination
Jul 15, 2025
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 15, 2026 169 days

Trademark Image

VAOCLEST

Basic Information

Serial Number
98860191
Filing Date
November 19, 2024
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jul 15, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Janina Gorbach

USPTO Deadlines

Next Deadline
169 days remaining
NOA E-Mailed - SOU Required
Due Date
January 15, 2026
Extension Available
Until July 15, 2026

Application History

14 events
Date Code Type Description Documents
Jul 15, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 17, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 24, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 16, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 16, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 16, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 15, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 19, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005